Mecillinam, a ␤-lactam antibiotic specific to penicillin-binding protein 2 (PBP 2) in Escherichia coli, blocks cell wall elongation and, indirectly, cell division, but its lethality can be overcome by increased levels of ppGpp, the nucleotide effector of the stringent response. We have subjected an E. coli K-12 strain to random insertional mutagenesis with a mini-Tn10 element. One insertion, which was found to confer resistance to mecillinam in relA ؉ and relA strains, was mapped at 75.5 min on the E. coli map and was located between the promoters and the coding sequence of the aroK gene, which codes for shikimate kinase I, one of two E. coli shikimate kinases, both of which are involved in aromatic amino acid biosynthesis. The mecillinam resistance conferred by the insertion was abolished in a ⌬relA ⌬spoT strain completely lacking ppGpp, and it thus depends on the presence of ppGpp. Furthermore, the insertion increased the ppGpp pool approximately twofold in a relA ؉ strain. However, this increase was not observed in relA strains, although the insertion still conferred mecillinam resistance in these backgrounds, showing that mecillinam resistance is not due to an increased ppGpp pool. The resistance was also abolished in an ftsZ84(Ts) strain under semipermissive conditions, and the aroK::mini-Tn10 allele partially suppressed ftsZ84(Ts); however, it did not increase the concentration of the FtsZ cell division protein. The insertion greatly decreased or abolished the shikimate kinase activity of AroK in vivo and in vitro. The two shikimate kinases of E. coli are not equivalent; the loss of AroK confers mecillinam resistance, whereas the loss of AroL does not. Furthermore, the ability of the aroK mutation to confer mecillinam resistance is shown to be independent of polar effects on operon expression and of effects on the availability of aromatic amino acids or shikimic acid. Instead, we conclude that the AroK protein has a second activity, possibly related to cell division regulation, which confers mecillinam sensitivity. We were able to separate the AroK activities mutationally with an aroK mutant allele lacking shikimate kinase activity but still able to confer mecillinam sensitivity.
Escherichia coli owes its rod shape to the rigidity of its peptidoglycan (also called cell wall or murein). The polymerization of this highly cross-linked macromolecule is catalyzed by inner membrane enzymes called penicillin-binding proteins (PBPs) (42) . Peptidoglycan growth during the cell cycle includes an elongation phase and a septation phase, processes which require particular peptidoglycan synthesis. PBP 2, coded for by the pbpA gene, is essential for elongation, as shown by the observation that when it is inactivated, the cells lose their rod shape and become spherical (53) . Moreover, mecillinam (34), a ␤-lactam which specifically inactivates PBP 2 (54, 55) , causes wild-type cells to become spherical and die, indicating that elongation is essential to cell survival (24, 37) . This conclusion is further supported by the inability of wild-type strains to tolerate a deletion of the pbpA gene (44) .
We attributed the lethality of PBP 2 inactivation to cell division inhibition (64) . However, PBP 2 is not an essential element of the septation apparatus, since mecillinam-resistant mutants can be isolated which survive as spheres and tolerate a pbpA deletion. One class consists of mutants which remain rod shaped in the absence of mecillinam but grow as spheres in its presence. These include aminoacyl-tRNA synthetase mutants, partially defective in aminoacylation (7, 62) , and cya and crp mutants (2, 23) , defective for the cyclic AMP (cAMP)-catabolite gene activator protein (CAP) complex, a transcriptional regulator (58) . A second class consists of mutants which grow as spheres even in the absence of mecillinam; they are mutated at the mre locus (65) (66) (67) .
Cell division, or septation, is an essential event in the E. coli cell cycle which is tightly controlled during balanced growth and is coupled to cell mass and protein synthesis (61) . The FtsZ protein has attracted much attention, since it is essential for septation (15) , it acts early (3), and it may be limiting for the process (71) (see also reference 57), and it is the target of all known endogenous cell division inhibitors (35) . Using immunoelectron microscopy, Bi and Lutkenhaus (4) observed that FtsZ, which is dispersed in the cytoplasm of nondividing cells, condenses to form a membrane-associated ring at the center of the cell at about the same time that a constriction appears. The formation of the FtsZ ring is the earliest known septation event and appears to be essential since it is always observed in dividing cells but is not seen when cell division inhibitors are induced (5) . FtsZ is able to bind and hydrolyze GTP (16, 40, 47) and to form tubulin-like filaments in vitro (9, 20, 41) , which suggests that it plays a structural role in septation, possibly constricting the cell envelope. We found that the lethality of PBP 2 inactivation is suppressed by overproduction of the FtsZ, FtsA, and FtsQ proteins (64) . This led us to suggest that the division block observed when PBP 2 is inactivated results from an insufficient division capacity in spherical cells, whose diameters are larger than those of rods. Thus, elongation might be essential simply because it keeps the cell diameter constant as the cell mass increases.
The nucleotide ppGpp was discovered through the dramatic increase in its concentration following amino acid starvation of RelA ϩ strains (11, 13) . This increase induces the stringent response (14) , whose major effect is a strong decrease in the transcription rate of stable RNA operons, probably via a direct interaction of ppGpp with RNA polymerase. This leads to a decrease in ribosome synthesis; ppGpp is thus an indicator of ribosome activity, and it adjusts the rate of ribosome formation to the availability of aminoacyl-tRNA. The ribosome-bound RelA protein is responsible for the increase in the ppGpp pool whenever the ratio of uncharged tRNA to charged tRNA increases, such as during amino acid starvation (49) . The presence of ppGpp in ⌬relA strains (38) indicates that E. coli has a second ppGpp synthetase, and the complete absence of the nucleotide in ⌬relA ⌬spoT strains strongly suggests that the second enzyme is SpoT (22, 73) , making this protein bifunctional since it is also the major ppGpp hydrolase (1, 29) . ⌬relA ⌬spoT strains display heterogeneous cell morphology, including filaments (22, 73) . This suggests that the presence of ppGpp during balanced growth promotes cell division, possibly by stimulating the transcription of cell division genes.
We have shown that the mecillinam resistance of aminoacyltRNA synthetase mutants requires RelA activity and that wildtype cells can be made mecillinam resistant simply by increasing the ppGpp pool via the overproduction of RelA activity (8, 26, 62) . Furthermore, the ftsZ84(Ts) mutant is partially suppressed by overexpression of RelA activity (reported in reference 45). These observations led us to suggest (64) that ppGpp is a positive regulator of FtsZ activity, possibly stimulating transcription of the ftsQAZ operon. The nucleotide thus might be one of the elements involved in coupling septation to cell mass and protein synthesis.
We speculated that the selection of mecillinam-resistant mutants in a relA genetic background might allow the identification of regulators of FtsZ or SpoT activity. We report here the selection and characterization of one mutant of this type, obtained by random insertional mutagenesis. We show that the insertion causes a deficiency in the expression of the aroK gene, which in turn causes mecillinam resistance by decreasing an AroK activity distinct from shikimate kinase, possibly related to the modulation of cell division capacity.
MATERIALS AND METHODS
Bacterial strains and phages. All of the strains used in this work are E. coli K-12 derivatives; the principal strains are described in Table 1 . During the course of this study, the parental strain GC3782 (60) was found to carry a presumed rpoS mutation which causes a delay in bubbling in the catalase test (30) and cotransduces with the relA251 mutation. Although this mutation does not affect the mecillinam resistance or sensitivity of any of the strains tested (data not shown), we constructed strain DV4 (rpoS ϩ ) for further analysis. To do this, strain DV1 was transduced to ⌬relA251 Km r rpoS ϩ (detected by the bubbling test), and this strain was transduced to argA::Tn10 relA ϩ Km s , and subsequently to Arg ϩ , to produce DV4. Strain DV15 is an Arg ϩ relA1 transductant obtained in a similar manner (donor strain, DV2); the presence of the relA mutation was detected by the inability of the organism to grow on minimal glucose plates supplemented with serine, methionine, and glycine (59) . The ⌬relA251 Km r and ⌬spoT207 Cm r mutations are from strain CF1693 (73) . To construct strain DV20, which has two kanamycin resistance markers, we introduced the ⌬relA251 allele into an argA:: Tn10 aroK3::kan strain by cotransduction with Arg ϩ . The ftsZ84(Ts) mutation from strain GC3443 (48) was introduced into strain DV23 by cotransduction with leu::Tn10, screening for thermosensitive growth at 42ЊC on Luria-Bertani (LB) plates lacking NaCl; one such clone was transduced to Leu ϩ . Strains ALO939, ALO863 (32) , and ANL11 (36), kindly provided by E. Boye, were the donors of the aroK::cat, urf74.3::mini-Tn10 (Tc r ), and urf74.3::kan insertions, respectively. The donor of the dam-13::Tn9 insertion was described previously (63) . The aroL::Tn10 and aroA::Tn10 insertions were from strains JP3123 and LCB273, respectively, kindly provided by B. Bachmann. We introduced the aroK3::kan mutation (which is Aro ϩ Km r ) into the aroB strain POP1010 (68); an aroK3::kan aroB transductant was used as the donor to construct strain DV14, which in turn was used as the donor to construct the The strains carrying various Tn10 transposons used for genetic mapping were from the Singer collection (52); the Hfr strains were described by Wanner (70) . P1 vir transduction and Hfr crosses were carried out as described by Miller (39) .
Phage NK1205 (27) was used as the mini-Tn10 donor. For the selection of insertional mutants, 3.5 ϫ 10 10 cells of an exponential culture of strain DV3 were infected with 5 ϫ 10 8 , 1 ϫ 10 9 , or 1.5 ϫ 10 9 NK1205 phage. After 30 min of preadsorption at 37ЊC, the cells were washed and resuspended in LB broth for 1 h and then plated on LB plates supplemented with kanamycin, mecillinam (1 or 10 g/ml), or kanamycin plus mecillinam (1 or 10 g/ml). Km r Mec r mutants were purified after 48 h of incubation at 37ЊC. The mean frequency of transposition from NK1205 onto the chromosome, calculated as Km r clones per infecting phage, was 6 ϫ 10
Ϫ5
. The plating efficiency of the uninfected culture was 5 ϫ 10 Ϫ5 on medium with 1 g of mecillinam per ml and 7 ϫ 10 Ϫ6 on medium with 10 g of mecillinam per ml. The frequency of Mec r mutants among Km r clones was 4 ϫ 10 Ϫ3 with 5 ϫ 10 8 phage and 6.7 ϫ 10 Ϫ4 with 1 ϫ 10 9 or 1.5 ϫ 10 9 phage. Media and growth conditions. The rich and minimal media used in this work were, respectively, LB broth (containing 10 g of NaCl per liter unless otherwise indicated) and M9 containing 0.2% glucose (39) . For ppGpp assays, we used MOPS (morpholinepropanesulfonic acid) medium (43) as modified by Bochner and Ames (6) , except that the phosphate concentration was 0.4 mM and the NaCl concentration was 10 g/liter. Shikimic acid (100 g/ml) and amino acids (100 g/ml) were added to minimal glucose medium when needed. Solid media contained 1.5% agar. Antibiotics were used at the following concentrations: chloramphenicol (Cm), 30 g/ml; kanamycin (Km), 50 g/ml; mecillinam (Mec), 1 or 10 g/ml; tetracycline (Tc), 40 g/ml; spectinomycin (Spc), 50 g/ml; and ampicillin (Amp), 100 g/ml.
The Lac Ϫ phenotype was tested on MacConkey lactose plates (39) . DNA techniques and plasmids. Plasmids were extracted and transformation was carried out as described by Sambrook et al. (50) . Sequence determinations were carried out with the Sequenase kit (U.S. Biochemicals). The inserts of plasmids pDV303 and pDV303-1 were sequenced on one strand by using suitable primers (Bioserve Biotechnologies); the point mutation in the aroK gene carried by pDV303-1 and the same region in pDV303 were sequenced on both strands. The low-copy-number vectors used in this work were pHSG576 (Cm r ) (56) and pCL1920 (Spc r ), plasmids that are present in about five copies per cell (31); pBluescript II KSϩ (pKSϩ; Amp r ) is a high-copy-number vector (Stratagene). PCR amplification was carried out with Taq polymerase from Perkin-Elmer. Synthetic primers (5Ј to 3Ј) were as follows: primer A, CTACCTTAACTTAAT GATTTTGATA; primer B, CCGGCACCCATAGGCCCAACC; primer C, AA CAGCTATGACCATG; primer D, GGGTGATCAGAATTCCGCGAGTTAG TGGTGTTTATCACGCC; and primer E, CCCCTGCAGCCACCTTAATTA CTGTACCCGC.
The aroK gene was amplified by PCR with primers D and E ( Fig. 1) , which create an EcoRI and a PstI site at the 5Ј and 3Ј ends of the gene, respectively. The resulting band was digested with these two enzymes and ligated into pCL1920, yielding plasmids pDV303 and pDV303-1. In these plasmids, a HindIII site is located downstream of the PstI site. Cloning of the EcoRI-HindIII insert of pDV303 into pKSϩ yielded plasmid pDV304, in which the aroK gene is located between two PstI sites. The PstI-PstI insert of pDV304 was cloned in pCL1920 to form plasmid pDV305. Digestion of pDV305 with MscI and SmaI followed by ligation yielded plasmid pDV306.
Assay of ppGpp. The basal levels of ppGpp were assayed (12) by 32 P labeling of cells growing in MOPS medium containing glucose (0.2%), all 20 amino acids (40 g/ml), and shikimic acid (100 g/ml). Nucleotides were extracted by adding ice-cold formic acid to 7.5 M, and samples were frozen and thawed twice before the insoluble material was pelleted in a microcentrifuge for 5 min at 4ЊC. Samples of the supernatant were spotted on polyethyleneimine plates (Polygram CEL 300; Macherey-Nagel), and two-dimensional chromatography was carried out in 3.3 M ammonium formate-4.2% boric acid, pH 7, and then in 1.5 M KH 2 PO 4 after the plates were washed with in methanol. Quantification was performed with the Ambis radioanalytic imaging system.
Immunoassay of FtsZ protein.
Immunoblots were carried out with anti-FtsZ serum, generously provided by Miguel Vicente. Strains were grown in LB broth. Samples equivalent to 1 ml at an optical density at 600 nm (OD 600 ) of 1.0 were cooled on ice, centrifuged, resuspended in 60 l of sodium dodecyl sulfate (SDS) sample buffer, heated at 100ЊC for 3 min, electrophoresed on SDS-10% polyacrylamide gels, and electrophoretically transferred to nitrocellulose. Blots were blocked overnight with 5% nonfat dry milk in Tris-buffered saline (137 mM NaCl, 20 mM Tris [pH 7.6], 0.1% Tween 20) and probed first with anti-FtsZ serum diluted 1:3,000 and then with 35 S-labeled anti-rabbit immunoglobulin G (Amersham) diluted 1:3,000. The radioactive bands were detected with a PhosphorImager (Molecular Dynamics) and quantified with the software Image Quant 1.33 (Molecular Dynamics).
Preparation of S100 extracts. Strains were grown in LB broth to an OD 600 of 1; cells were harvested from 1 liter of medium and washed once with 300 ml of M9. The washed-cell pellets were resuspended in 3 ml of 50 mM Tris HCl buffer, . The four lower maps show plasmids constructed to contain either the aroK and aroB genes (pDV302) or the aroK region (pDV303, pDV304, and pDV306). Thick lines symbolize vector DNA of pKSϩ or pCL1920, as indicated. Simple arrows indicate the direction of transcription. Primers A to E, which were used for amplification of the aroK gene and for determination of the insertion site, are represented by arrows with boxes at their origins.
kinase activity was observed after 2 months of storage. The protein concentration was measured by the Bradford assay (Bio-Rad).
Test for shikimate kinase activity. Tests were carried out in 10 l of 20 mM Tris (pH 7.5)-5 mM MgCl 2 -100 mM NaCl. After 1 min of preincubation separately at 37ЊC, 5 l of extract was added to 5 l of twofold-concentrated reaction mixture, yielding final concentrations of unlabeled ATP and [␥-32 P]ATP as specified in Fig. 5 and of 5.7 mM shikimate. Samples (2 l) were spotted directly on polyethyleneimine plates and chromatographed by ascending development in 1 M LiCl; lower concentrations of LiCl were less effective in separating shikimate phosphate from the origin.
RESULTS
Isolation of mini-Tn10 insertions conferring mecillinam resistance. The plating efficiency of RelA ϩ strains on LB plates containing 1 to 10 g of mecillinam per ml is about 10
Ϫ4
. This value is considerably lower in relA1 strains (62) , suggesting that the majority of mecillinam-resistant mutants of RelA ϩ strains owe their phenotype to a RelA-dependent increase in the ppGpp pool, as is the case for aminoacyl-tRNA synthetase mutants (62) . To isolate RelA-independent mecillinam-resistant mutants, we made random mini-Tn10 (Km r ) insertions in the relA1 strain DV3 and selected for mecillinam resistance (see Materials and Methods). Of 45 Km r Mec r mutants, 28 grew after purification on the same medium (5 when mecillinam was present at 10 g/ml and 23 when the drug concentration was 1 g/ml). The insertions of these clones were backcrossed into strain DV3, and the Km r transductants were tested for mecillinam resistance. In 22 cases, mecillinam resistance was not cotransduced with kanamycin resistance (less than 2% cotransduction). In three cases, mecillinam resistance and kanamycin resistance were cotransducible, but not with 100% efficiency (50% for two insertions and 17% for the third). In the last three cases, kanamycin resistance and mecillinam resistance were 100% cotransducible (48 Km r transductants tested), showing that the insertions were responsible for mecillinam resistance. Two of these insertions conferred resistance to mecillinam at 10 g/ml and showed RecA-dependent genetic instability, as indicated by the spontaneous segregation of Km s Mec s clones when kanamycin was omitted from the culture medium of recA ϩ (but not recA1) strains carrying these insertions (data not shown). The third insertion, mcr-3::Tn10, is stable and confers resistance to mecillinam at 1 g/ml but not at 10 g/ml. The characterization of this insertion, initially designated mcr-3::kan, is reported here.
Identification of the gene affected by the mcr-3::kan insertion. We roughly mapped the mcr-3::kan insertion by Hfr crosses, using the mcr-3::kan derivative of DV3, which is Cm r ( The mini-Tn10 used has no PstI sites. We unsuccessfully attempted to clone the Km r marker of strain DV3 mcr-3::kan in the low-copy-number Cm r vector pHSG576 by using PstIdigested chromosomal DNA. We were successful when the chromosomal DNA was digested with PstI and EcoRI and cloned into pHSG576 that had been digested with these two enzymes. The Cm r Km r plasmids isolated in this case all carried a common EcoRI-EcoRI fragment of 3.6 kb and EcoRIPstI linker fragments of various sizes. The 3.6-kb EcoRI-EcoRI fragment carried the Km r marker; it was subcloned in the high-copy-number vector pKSϩ to produce plasmid pDV302 (Fig. 1) .
Plasmid pDV302 was partially sequenced near one end of the mini-Tn10 (Fig. 1 ) (see Materials and Methods) by using primer A to determine the exact point of insertion. The sequence obtained was identical to that of aroK (72) . The sequence obtained with primer B indicated that the insertion occurred downstream of the two promoters of the aroK gene and upstream of its start codon ( Fig. 1 and 2) . We therefore renamed the mcr-3::kan insertion aroK3::kan. By sequencing with primer C, we found that pDV302 also carries the entire aroB coding sequence, downstream of aroK (Fig. 1 ). An aroK gene disruption by the insertion of a chloramphenicol resistance cassette reported previously (33) also conferred mecillinam resistance when transduced into strain DV4 (Fig. 2 ) (see also Table 4 , strain DV6).
The aroK gene is the first gene in a complex operon containing the genes aroK-aroB-urf74.3-dam-rpe-gph-trpS, with a number of internal promoters (32, 36) . The aroB gene codes for an enzyme required for the biosynthesis of aromatic amino acids and which acts before shikimic acid formation (46) (Fig.  3) ; urf74.3 codes for a 46-kDa protein of unknown function (25) ; dam is the structural gene for DNA adenine methylase, which methylates the adenines in GATC sequences of doublestranded DNA (21, 28) ; rpe codes for ribose-5-phosphate epimerase; gph codes for glycolate-phosphate phosphatase (36); and trpS is the structural gene for tryptophanyl-tRNA synthetase (19) . Since the mini-Tn10 element is expected to have polarity effects on downstream genes, the aroK3::kan insert could reduce the expression of all the above-mentioned genes to varying degrees. We present below physiological, genetic, and biochemical characterizations of this mutant, showing that its mecillinam resistance results from the loss of a second activity of the aroK gene product.
Physiological characterization. Microscopic observation revealed that the aroK3::kan mutant had a normal rod shape in the absence of mecillinam and was spherical in its presence. This shows that it has an active PBP 2 which is still able to bind mecillinam and that it is not defective for MreB activity. The aroK3::kan mutant is Lac ϩ on MacConkey lactose medium and therefore is not defective for the cAMP-CAP complex. The only phenotype conferred by the aroK3::kan mutation besides mecillinam resistance is a slightly slower growth rate than that of the parental strain, even in LB broth.
Mecillinam resistance in the aroK3::kan mutant and ppGpp. Partial inactivation of aminoacyl-tRNA synthetases confers mecillinam resistance via a RelA-dependent increase in the ppGpp pool (62). The aroK3::kan insertion could slightly decrease the expression of the tryptophanyl-tRNA synthetase, although this is unlikely to be the cause of its mecillinam resistance since it was selected in a relA1 strain. However, the RelA1 protein retains low ppGpp synthetase activity (38) , and E. coli possesses a second ppGpp synthetase, presumably the product of the spoT gene (22, 73) . We therefore constructed the strains listed in Table 2 and tested their mecillinam resistance. In a relA ϩ background, as in relA1 and ⌬relA, the aroK3:: kan insertion conferred resistance to mecillinam at 1 g/ml but not at 10 g/ml. However, in the ⌬relA ⌬spoT background, in which ppGpp is completely absent, mecillinam resistance was totally lost (strain DV22), showing that it is ppGpp dependent.
In parallel, we determined the effect of the aroK3::kan mu- tation on ppGpp levels. Since the mecillinam resistance of strain DV5 is abolished at low NaCl concentrations (data not shown), the assays were carried out in the presence of a higher NaCl concentration than is present in classical MOPS medium (10 g/liter instead of 2.9). On this medium, as on LB plates (10 g of NaCl per liter), the aroK ϩ strains were all sensitive to mecillinam whereas the aroK3::kan (spoT ϩ ) strains were resistant. Strains DV15 (relA1) and DV19 (⌬relA) had about twofold-lower ppGpp concentrations than strain DV4 ( Table 2 ). The aroK3::kan mutation caused about a twofold increase in the basal ppGpp concentration in the relA ϩ strain but not in the relA1 or ⌬relA backgrounds, showing that the increase is RelA dependent. Since the relA1 aroK3::kan and ⌬relA aroK3:: kan strains are mecillinam resistant but have less ppGpp than the parental strain DV4, which is mecillinam sensitive, we conclude that the mecillinam resistance conferred by aroK3:: kan is not due to an increased ppGpp concentration.
Mecillinam resistance of the aroK3::kan mutant is FtsZ dependent. Mecillinam resistance is conferred on wild-type strains by overproduction of the FtsZ, FtsA, and FtsQ proteins but not by overproduction of just FtsA and FtsQ (64) . To see whether the mecillinam resistance conferred by aroK mutations involves FtsZ, we introduced the aroK3::kan allele into the ftsZ84(Ts) strain DV23 and tested the mecillinam resistance of the transductant (DV24) at different temperatures. On LB plates containing 10 g of NaCl per liter, neither this transductant nor the parents, DV23 and DV5, had reduced plating efficiency at 42ЊC ( Table 3 (Table 3) . Thus, partial inactivation of the FtsZ84 protein abolishes the mecillinam resistance of the aroK3::kan mutant.
The aroK3::kan mutation partially suppresses ftsZ84(Ts). The phenotype conferred by the ftsZ84(Ts) mutation includes filamentation at high temperature and, on media of low osmolarity, loss of colony-forming ability; both defects are suppressed by overproduction of the altered protein FtsZ84 (69). The aroK3::kan mutation does not suppress the thermosensitivity of the ftsZ84(Ts) mutant in LB broth completely lacking NaCl, suggesting that it does not cause massive overproduction of FtsZ. However, under less stringent conditions, partial suppression of ftsZ84(Ts) was observed. When grown at 30ЊC in LB broth containing 5 g of NaCl per liter, the colony size for strain DV23 was larger than that for DV24, reflecting the slight growth defect due to the aroK mutation. At 37ЊC, although there was no significant decrease in plating efficiency, the colony size for strain DV23 was smaller than that for DV24, and DV23 generated faster-growing revertants at a high frequency. At 42ЊC, neither strain was able to form colonies on this medium, indicating that the suppression observed was only partial.
We next looked for suppression of filamentation in liquid culture. Overnight 30ЊC cultures of strains DV23 (aroK ϩ ftsZ84) and DV24 (aroK3::kan ftsZ84) in LB broth containing 10 g of NaCl per liter were diluted 1,000-fold in LB broth containing 5 g of NaCl per liter and incubated at 30, 37, or 42ЊC. Samples of all cultures were taken at OD 600 of 0.2 and 0.4 (about six and seven generations, respectively). Microscopic observation revealed that both strains had normal morphology at 30ЊC, with the cultures composed exclusively of small rod-shaped cells. At 37ЊC, the cells of strain DV23 were heterogeneous in size, with small and elongated cells and some long filaments, whereas DV24 cells remained morphologically normal. At 42ЊC, strain DV23 formed very long filaments while the DV24 cells were much shorter and more numerous at a given OD 600 (data not shown).
From these results, we conclude that the aroK3::kan mutation partially suppresses the phenotype conferred by the ftsZ84(Ts) mutation. This suggests that the aroK3::kan mutation increases FtsZ activity. However, quantitative immunoassaying of the FtsZ protein showed that its concentration is the same in strains DV1 (aroK ϩ ) and DV25 (aroK3::kan) (Fig. 4) , indicating that the suppression of the ftsZ84(Ts) mutation by aroK3::kan does not reflect increased synthesis of the FtsZ protein. It is possible that the absence of AroK causes a qualitative change in the FtsZ protein, increasing its activity (see Discussion).
Polarity of aroK insertions.
The aroK gene codes for shikimate kinase I (33), one of the two shikimate kinases of E. coli; shikimate kinase II is the product of the unlinked aroL gene (17) . Shikimate kinase activity is essential for the synthesis of aromatic amino acids. Either kinase alone is sufficient for growth in a minimal medium (17, 33) , but aroK aroL double mutants have an aromatic requirement that cannot be satisfied by shikimate (33) .
The previously described aroK::cat mutation has been shown to decrease the transcription of downstream genes; it causes aromatic-amino acid auxotrophy which can be satisfied by shikimate and therefore reflects a polarity effect on aroB rather than the loss of shikimate kinase activity (32, 33) . We confirmed this observation (Table 4 , strain DV6) but found that strain DV5 (aroK3::kan) can grow on minimal glucose plates, although the colonies are slower to appear than those of the parental strain. Since shikimate permits faster growth, we conclude that the aroK3::kan insertion decreases but, unlike aroK::cat, does not completely abolish expression of the aroB gene. However, either insertion, when combined with an aroL::Tn10 mutation (inactivating shikimate kinase II), abolishes the ability to grow on glucose shikimate plates (strains DV10 and DV11). This suggests that the aroK3::kan insertion We inactivated aroB, urf74.3, and dam either singly, in pairs, or concomitantly to test whether the mecillinam resistance conferred by insertions in aroK is due to a polarity effect on downstream genes. All aroK ϩ strains were sensitive to mecillinam (Table 4 and data not shown). Moreover, all of the aroK3::kan strains were resistant, indicating that none of these functions is required for the insertion to confer mecillinam resistance (Table 4) . It is thus unlikely that this resistance is due to decreased expression of the genes following aroK in the transcription unit.
As final proof that the mecillinam resistance observed results simply from decreased expression of aroK, we amplified the P1-P2-aroK region of strain DV1 (aroK ϩ ) by PCR and cloned it into the low-copy-number vector pCL1920 (see Materials and Methods). The resulting plasmid, pDV303 (Fig. 1) , carries the minimal wild-type aroK gene, whose sequence was found to be identical to the one which was recently published (72) . Plasmid pDV303 suppressed the mecillinam resistance of aroK3::kan and aroK::cat strains (data not shown) and also suppressed both the mecillinam resistance and the aromatic auxotrophy of the aroK3::kan aroL::Tn10 double mutant (Table 4). This result proves that mecillinam resistance results from decreased expression of the aroK gene and not from polarity effects on expression of downstream genes in the operon.
aroK mutants can survive without PBP 2. Although aroK mutants are completely resistant to mecillinam at 1-g/ml, they do not form colonies on media containing 10 g of the antibiotic per ml. To see whether this reflects an inability to survive in the complete absence of PBP 2, we tried to transduce a deletion of the PBP 2 structural gene, ⌬(rodA-pbpA)::kan, into aroK strains by using a linked Tn10 marker (donor strain DV26). In the aroK::cat strain DV6, of 44 Tc r transductants, 38 had become Km r and displayed a slower growth rate; the cells of Km r transductants were spherical, confirming the lack of PBP 2. In the aroK3::kan strain DV5, which is already Km r , of 40 Tc r transductants, 31 grew more slowly and had acquired a spherical morphology. When, as a control, we transduced strain DV4, none of the 48 Tc r transductants were Km r . We conclude that aroK mutants have acquired the ability to grow and divide in the complete absence of PBP 2.
AroK possesses a second activity. The loss of shikimate kinase I activity does not confer auxotrophy since it is compensated for by shikimate kinase II. Nevertheless, it was possible that a slightly reduced efficiency of aromatic amino acid biosynthesis was the cause of mecillinam resistance in aroK mutants. We tested this hypothesis by blocking the pathway at other steps. A block before shikimate, in the aroB mutant, or after shikimate phosphate, in the aroA::Tn10 mutant (Fig. 3) , did not result in mecillinam resistance (Table 4) . Furthermore, neither of these blocks prevented aroK insertions from conferring mecillinam resistance. The aroB aroK3::kan strain, which was presumed to be unable to carry out endogenous shikimate synthesis, remained mecillinam resistant even in the absence of exogenous shikimate, as seen on plates of M9 glucose supplemented with all 20 amino acids, p-hydroxybenzoic acid, and p-aminobenzoic acid (0.2 mM each). Similarly, the inactivation of shikimate kinase II by an aroL::Tn10 mutation did not confer mecillinam resistance and did not prevent resistance in aroK mutants. This shows that the two shikimate kinases are not equivalent and indicates that the activity of the AroK protein which makes cells sensitive to mecillinam does not require the presence of shikimate (it is absent in the aroB and aroK::cat mutants). Therefore, AroK must possess a second activity, distinct from shikimate kinase and not involved in aromatic amino acid biosynthesis.
We separated these two activities mutationally. In our cloning of the aroK gene (see above), we fortuitously obtained plasmid pDV303-1 as a PCR-induced mutant which suppressed the mecillinam resistance of the aroK3::kan aroL:: Tn10 strain but did not suppress its auxotrophy for aromatic amino acids (Table 5 ). The aroK gene in pDV303-1 has a single sequence change, causing a Leu-1333Pro substitution (Fig. 2) . To see whether a C-terminal deletion of the AroK protein had the same effect as the Leu-1333Pro mutation, we constructed plasmid pDV306 (Fig. 1) ; this plasmid corrected neither the mecillinam resistance nor the auxotrophy of the aroK3::kan aroL::Tn10 strain. The properties of plasmid pDV303-1, together with the results presented above, show that the AroK protein has a second activity which can be disassociated from shikimate kinase activity and is involved in mecillinam sensitivity.
Shikimate kinase tests. We tested S100 extracts of various strains for shikimate kinase activity to verify deductions from growth requirements. The ability to phosphorylate shikimate was measured after resolving shikimate phosphate from both the [␥-32 P]ATP phosphate donor and its inorganic hydrolysis products, phosphate and pyrophosphate, by thin-layer chromatography in 1 M LiCl. A high shikimic acid concentration (5.7 mM) was used to allow the detection of either source of shikimate kinase activity, about 30-fold above the K m for the aroLencoded source of shikimate kinase and approaching the K m value (Ն20 mM) of the aroK-encoded shikimate kinase (18) . In these crude extracts, shikimate kinase competed with other sources of ATPase; in the presence or absence of shikimic acid, release of labeled P i from 2 mM [␥-32 P]ATP was linear with time during the first 10 min (data not shown) and hydrolysis of input ATP was complete by 60 min (Fig. 5) .
One radioactive spot, which was presumed to be shikimate phosphate, appeared only when shikimic acid was added together with extracts of aroL ϩ strains (Fig. 5A) (Fig. 5C, lanes 1  to 3) . Under these conditions, there was no detectable activity in extracts of the aroL::Tn10 aroK3::kan strain DV10 (Fig. 5C , lanes 7 to 9).
AroK-dependent shikimate kinase could be overexpressed to levels detected under the same assay conditions as described for Fig. 5A , i.e., 2 mM [␥- 32 P]ATP at 25 Ci/mol, by increasing the aroK gene copy number with aroK cloned in strain DV11, which is otherwise devoid of shikimate kinase because of aroK::cat and aroL::Tn10 insertions (Fig. 5B) . Extracts of strains carrying the aroK gene cloned in a low-copy-number pSC101 derivative (pDV303) and in a high-copy-number pKSϩ plasmid (pDV304) gave 4.6 and 35%, respectively, of FIG. 5 . Shikimate kinase assays with S100 extracts. Assays were carried out as described in Materials and Methods, with each 10-l reaction mixture containing 12.5 g of protein, 5.7 mM shikimic acid, and [␥- VOL. 178, 1996 INACTIVATION OF E. COLI AroK CAUSES MECILLINAM RESISTANCE 3825 the total input radioactivity associated with putative shikimate phosphate after 60 min of incubation (Fig. 5B) . In each case, no activity was found in this region of the chromatogram either in the absence of added shikimic acid or when we used extracts from strain DV11 bearing the vector controls pCL1920 and pKSϩ and assayed them in the presence of shikimate (Fig. 5B and data not shown). In addition, we did not detect shikimate kinase activity in extracts of cells bearing pDV303-1, the aroK (L133P) allele cloned in pCL1920, under these conditions or when the assay was performed under conditions that allowed detection of shikimate kinase expressed from a single copy of aroK on the chromosome (Fig. 5C, lanes 4 to 6) . In summary, the phosphorylated compound we believe to be shikimate phosphate could be detected in all extracts of Aro ϩ strains (aroL ϩ and/or aroK ϩ ) but was never found in aroL aroK extracts, in reaction mixtures lacking added shikimic acid, or in the absence of extract. The shikimate kinase specific activity associated with AroL was higher than the specific activity associated with AroK, as expected (18) , and the low activity associated with AroK increased with increasing gene copy number, eventually exceeding that present in extracts from single-copy aroL ϩ strains. The in vitro assays further confirm that the L133P mutation in aroK carried by plasmid pDV303-1 inactivates the AroK shikimate kinase activity.
DISCUSSION
From a collection of random mini-Tn10 insertions we selected one which confers resistance to mecillinam, a ␤-lactam which specifically inhibits PBP 2. Surprisingly, the insertion proved to lie between the promoters and the coding sequence of the aroK gene, which codes for shikimate kinase I, an enzyme of the aromatic pathway. This location, which was determined by sequencing the insert ends, is based on the revised aroK sequence (72), which we confirmed here. The insertion, called aroK3::kan, effectively abolishes shikimate kinase I activity, both in vivo and in vitro. An aroK::cat insertion, in which the chloramphenicol cassette lies within the aroK coding sequence, also confers mecillinam resistance. The aroK gene is promoter proximal in a complex operon which has several internal promoters. However, the mecillinam resistance clearly resulted from the loss of AroK, since plasmid pDV303, carrying only the aroK ϩ gene, restored antibiotic sensitivity. We have previously shown that an increase in the basal level of the nucleotide ppGpp makes E. coli mecillinam resistant (8, 26, 62) . In a relA ϩ background, the aroK3::kan mutation causes a doubling of the ppGpp concentration. This is sufficient to make cells mecillinam resistant (26) and therefore seemed to offer the key to understanding why aroK mutants can grow and divide in the absence of PBP 2. However, in a relA1 or ⌬relA context, the aroK3::kan allele had little effect on the ppGpp level, which in both strains was lower than that observed in the wild type, yet the aroK relA strains remained mecillinam resistant. The mecillinam resistance thus cannot be explained by an increased ppGpp concentration, although it does still seem to require either the nucleotide or the SpoT protein itself, since the aroK ⌬relA ⌬spoT triple mutant, which lacks ppGpp, is mecillinam sensitive.
We have also shown that E. coli can be made mecillinam resistant by increasing the concentration of the FtsZ, FtsA, and FtsQ proteins (but not by increasing FtsA and FtsQ alone), even in a relA1 strain (64) . This means that a higher division capacity is required for growth in the absence of PBP 2 (as a sphere) than for growth with functional PBP 2 (as a rod) (8, 62) . This remains true in the aroK3::kan mutant, in which decreasing the FtsZ activity by cultivating a thermosensitive mutant under semipermissive conditions made the strain sensitive to PBP 2 inactivation by mecillinam. Furthermore, the aroK3::kan allele partially suppresses the ftsZ84(Ts) mutation, suggesting that it increases FtsZ activity. Direct measurement of the amount of FtsZ protein, however, revealed no difference between aroK3::kan and wild-type strains; our immunoassay should detect as little as a 15% increase. We previously suggested the possibility that the FtsZ protein must be activated to carry out septation and presented evidence that ppGpp does not itself activate FtsZ (64) . It is possible that in aroK mutants, as in the presence of high ppGpp concentrations, FtsZ is more efficiently activated than in the wild type, providing a higher division capacity with the same amount of FtsZ protein. The mechanism of this hypothetical activation and the role played by AroK remain to be determined.
Although the aroK gene product has shikimate kinase activity (reference 33 and this work), it has been reported to have a K m of greater than 20 mM for shikimic acid, compared with 0.2 mM for shikimate kinase II, suggesting that it may have another physiological function unrelated to the phosphorylation of shikimate (18) . We have shown here that its function in making E. coli sensitive to mecillinam is indeed distinct from its shikimate kinase activity. First of all, aroK mutants are mecillinam resistant even in an aroB genetic background, in which there is presumably no endogenous synthesis of shikimic acid (see Fig. 3 ), and in a medium devoid of shikimic acid. Second, we isolated a mutant allele of aroK which had lost shikimate kinase activity, both in vivo and in vitro, but still restored mecillinam sensitivity to an aroK strain.
The nature of the second activity of the aroK gene product is not known. The results presented here suggest that AroK phosphorylates (or otherwise modifies) some substrate other than shikimate and that this product results in a lower division potential. One particularly appealing possibility is that AroK can act as a protein kinase, perhaps phosphorylating a division protein such as FtsZ, FtsA, or FtsQ, thereby lowering the cell's division potential. It is interesting to note, in this context, that FtsA is thought to be phosphorylated in vivo (51) . Studies to determine the nature of the second reaction catalyzed by AroK are currently in progress.
